iCoreConnect 10-K/A 22 Apr 21 2020 FY Annual report (amended) Financial data

Cover

Cover - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Apr. 22, 2021	Jun. 30, 2020
Cover [Abstract]
Entity Registrant Name	iCoreConnect Inc.
Entity Central Index Key	0001408057
Document Type	10-K/A
Amendment Flag	true
Amendment Description	iCoreConnect, Inc. (the ''Company'') is filing this Amendment No. 1 (this ''Amendment'') to its Annual Report on Form 10-K for the fiscal year ended December 31, 2020 (the ''Original Form 10-K''), as originally filed with the Securities and Exchange Commission (the ''SEC'') on April 15, 2021, to attach the XBRL file left off of the April 15, 2021 filing.
Entity Voluntary Filers	No
Current Fiscal Year End Date	--12-31
Entity Well Known Seasoned Issuer	No
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Dec. 31, 2020
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2020
Entity Common Stock Shares Outstanding		124,503,233
Entity Public Float			$ 9,700,000
Document Annual Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2020	Dec. 31, 2019
ASSETS
Cash and cash equivalents	$ 7,619	$ 445,000
Accounts receivable, net	126,472	101,000
Prepaid expenses and other current assets	20,103	8,000
Total current assets	154,194	554,000
Property and equipment, net	2,405	6,000
Right of use lease asset - operating	150,477	53,000
Software development costs, net	768,907	625,000
Acquired technology, net	753,794	891,000
Customer relationships, net	369,524	0
Goodwill	491,376	393,000
Total long-term assets	2,536,483	1,968,000
TOTAL ASSETS	2,690,677	2,522,000
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Accounts payable and accrued expenses	1,664,125	1,001,000
Operating lease liability, current portion	89,088	55,000
Current maturities of long-term debt	1,429,207	880,000
Deferred revenue, current portion	2,775	0
Total current liabilities	3,185,195	1,936,000
Long-term debt, net of current maturities	0	13,000
Operating lease liability, net of current portion	61,389	0
Deferred revenue, net of current portion	73,033	108,000
Total long-term liabilities	134,422	121,000
TOTAL LIABILITIES	3,319,617	2,057,000
STOCKHOLDERS' EQUITY (DEFICIT)
Common Stock par value $0.001; 600,000,000 shares authorized; Issued and Outstanding: 90,081,336 as of December 31, 2020 and 67,476,089 as of December 31, 2019	90,081	67,000
Additional paid-in-capital	77,112,060	74,738,040
Accumulated deficit	(77,831,081)	(74,340,000)
TOTAL STOCKHOLDERS' EQUITY (DEFICIT)	(628,940)	465,040
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$ 2,690,677	$ 2,522,000

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2020	Dec. 31, 2019
STOCKHOLDERS' EQUITY
Common stock, shares par value	$ 0.001	$ 0.001
Common stock, shares authorized	600,000,000	600,000,000
Common stock, shares issued	90,081,336	67,476,089
Common stock, shares Outstanding	90,081,336	67,476,089

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
CONSOLIDATED STATEMENTS OF OPERATIONS
Revenue	$ 2,123,587	$ 1,014,000
Cost of sales	1,008,843	305,000
Gross profit	1,114,744	709,000
Expenses
Selling, general and administrative	3,447,014	3,434,000
Depreciation and amortization	906,060	655,000
Total operating expenses	4,353,074	4,089,000
Loss from operations	(3,238,330)	(3,380,000)
Other income (expenses)
Interest expense	(238,820)	(236,000)
Other income (expense)	(50,733)	(64,000)
Gain on cancellation of liabilities	36,642	697,000
Total other income (expense)	(252,911)	397,000
Net loss	$ (3,491,241)	$ (2,983,000)
Net loss per share available to common stockholders, basic and diluted	$ (0.05)	$ (0.05)
Weighted average number of shares, basic and diluted	76,459,645	58,546,699

CONSOLIDATED STATEMENT OF CHANG

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Balance, shares at Dec. 31, 2018		50,864,131
Balance, amount at Dec. 31, 2018	$ (958,136)	$ 50,864	$ 70,335,000	$ (71,344,000)
Cumulative adjustment for the adoption of a new accounting pronouncement (Note 3)	(13,000)	$ 0	0	(13,000)
Stock issued for cash and conversion of notes payable, shares		12,435,759
Stock issued for cash and conversion of notes payable, amount	3,217,000	$ 12,000	3,205,000	0
Stock issued for services, shares		66,666
Stock issued for services, amount	17,000	$ 0	17,000	0
Stock compensation expense, shares		1,808,526
Stock compensation expense, amount	610,000	$ 2,000	608,000	0
Stock issued for acquisition of technology (Note 12), shares		2,301,007
Stock issued for acquisition of technology (Note 12), amount	575,000	$ 2,000	573,000	0
Net loss	(2,983,000)	0	0	(2,983,000)
Prior period rounding adjustment	176	$ 612	(596)	160
Balance, shares at Dec. 31, 2019		67,476,089
Balance, amount at Dec. 31, 2019	465,040	$ 67,476	74,737,404	(74,339,840)
Stock compensation expense, shares		2,124,693
Stock compensation expense, amount	423,300	$ 2,125	421,175	0
Net loss	(3,491,241)	$ 0	0	(3,491,241)
Stock issued for cash, shares		7,128,002
Stock issued for cash, amount	1,040,000	$ 7,128	1,032,872	0
Stock issued for conversion of convertible notes payable, shares		6,761,558
Stock issued for conversion of convertible notes payable, amount	201,600	$ 6,762	194,838	0
Stock issued as origination fee in convertible debt agreement, shares		50,000
Stock issued as origination fee in convertible debt agreement, amount	4,500	$ 50	4,450	0
Stock issued for asset acquisition of TrinIT (Note 8), shares		730,000
Stock issued for asset acquisition of TrinIT (Note 8), amount	183,000	$ 730	182,270	0
Stock issued for conversion of accounts payable, shares		1,000,000
Stock issued for conversion of accounts payable, amount	250,780	$ 1,000	249,781	0
Stock issued for stock option exercises, shares		5,000
Stock issued for stock option exercises, amount	1,000	$ 5	995	0
Stock issued as commitment fee on note, shares		250,000
Stock issued as commitment fee on note, amount	37,500	$ 250	37,250
Stock issued as true-up portion of purchase agreement for Claricare, shares		4,555,994
Stock issued as true-up portion of purchase agreement for Claricare, amount	255,581	$ 4,556	251,025
Balance, shares at Dec. 31, 2020		90,081,336
Balance, amount at Dec. 31, 2020	$ (628,940)	$ 90,081	$ 77,112,060	$ (77,831,081)

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITTIES
Net loss	$ (3,491,241)	$ (2,983,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	6,595	5,000
Amortization expense	898,622	650,000
Change in allowance for doubtful accounts	60,000	5,000
Gain on cancellation of liabilities	(12,642)	(697,000)
Stock issued for services	0	17,000
Stock compensation expense	422,175	610,000
Non-cash interest expense	55,000	0
Changes in assets and liabilities:
Accounts receivable	(85,472)	118,000
Prepaid expenses	(6,103)	1,000
Right of use asset, net of lease liability	(2,000)	(11,000)
Accounts payable and accrued expenses	922,767	625,000
Deferred revenue	(38,192)	(7,000)
NET CASH USED IN OPERATING ACTIVITIES	(1,270,491)	(1,667,000)
INVESTING ACTIVITIES
Cash portion of consideration paid to acquire ClariCare	0	(50,000)
Cash portion of consideration paid to acquire TrinIT (see Note 8)	(374,900)	0
Additions to capitalized software	(543,000)	(423,000)
NET CASH USED IN INVESTING ACTIVITIES	(917,900)	(473,000)
FINANCING ACTIVITES
Net proceeds from debt	676,000	123,000
Payments on debt	(70,793)	(736,000)
Proceeds from issuance of common stock	1,050,488	3,197,000
Proceeds from exercise of employee stock options	1,000	0
Conversion of convertible debt into common stock	94,315
NET CASH PROVIDED BY FINANCING ACTIVITIES	1,751,010	2,584,000
NET CHANGE IN CASH	(437,381)	444,000
CASH AND CASH EQUIVALENTS AT BEGINNING OF THE PERIOD	445,000	1,000
CASH AND CASH EQUIVALENTS AT END OF THE PERIOD	7,619	445,000
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid during the period for interest	94,126	195,000
Stock issued for acquisition of TrinIT	183,000
Stock issued for acquisition of technology	0	575,000
Stock issued for conversion of convertible notes payable	240,315	0
Stock issued for conversion of notes payable	0	20,000
Stock issued for conversion of accounts payable	$ 250,000	$ 75,000

NATURE OF OPERATIONS

NATURE OF OPERATIONS	12 Months Ended
	Dec. 31, 2020
NATURE OF OPERATIONS
Note 1 - NATURE OF OPERATIONS	iCoreConnect Inc., (the “Company”), a Nevada Corporation, builds secure cloud-based HIPAA compliant communications systems, productivity and technology framework software focused on healthcare, although the core technology can be adopted to other vertical markets that require a high degree of secure data communication, such as the legal, financial and education fields.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Note 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Basis of Presentation and Principles of Consolidations The accompanying consolidated financial statements are presented in United States dollars and include the accounts of the Company’s wholly owned subsidiaries, with all intercompany transactions eliminated. They have been prepared on the accrual basis in accordance with accounting principles generally accepted in the United States (GAAP).Significant accounting principles followed by the Company and the methods of applying those principles, which materially affect the determination of financial position, results of operations and cash flows are summarized below. Fair Value of Financial Instruments The Company measures certain financial assets at fair value. Fair value is determined based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, as determined by either the principal market or the most advantageous market. Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy, as follows: Level 1 — Quoted prices in active markets for identical assets or liabilities. Level 2 — Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 — Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities. Cash and Cash Equivalents The Company classifies highly liquid temporary investments with an original maturity of three months or less when purchased as cash equivalents. The Company maintains cash balances at various financial institutions. Balances at United States banks are insured by the Federal Deposit Insurance Corporation up to $250,000. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risk for cash on deposit. Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are customer obligations due under normal trade terms. We maintain an allowance for doubtful accounts for estimated losses resulting from the potential inability of certain customers to make required future payments on amounts due us. Management determines the adequacy of this allowance by periodically evaluating the aging and past due nature of individual customer accounts receivable balances and considering the customer’s current financial situation as well as the existing industry economic conditions and other relevant factors that would be useful in assessing the risk of collectability. If the future financial condition of our customers were to deteriorate, resulting in their inability to make specific required payments, additions to the allowance for doubtful accounts may be required. In addition, if the financial condition of our customers improves and collections of amounts outstanding commence or are reasonably assured, then we may reverse previously established allowances for doubtful accounts. The Company has estimated and recorded an allowance for doubtful accounts of $77,000 and $17,000 as of December 31, 2020 and 2019, respectively. Property, Equipment and Depreciation Property, equipment, and leasehold improvements are recorded at their historical cost. Depreciation and amortization have been determined using the straight-line method over the estimated useful lives of the assets which are computers and office equipment (3 years) and for office furniture and fixtures (7 years). The cost of repairs and maintenance is charged to operations in the period incurred. Software Development Costs and Acquired Software The Company accounts for software development costs, including costs to develop software products or the software component of products to be sold to external users. In accordance with ASC 985-730, Computer Software Research and Development, research and planning phase costs are expensed as incurred and development phase costs including direct materials and services, payroll and benefits and interest costs are capitalized. We have determined that technological feasibility for our products to be marketed to external users was reached before the release of those products. As a result, the development costs and related acquisition costs after the establishment of technological feasibility were capitalized as incurred. Capitalized costs for software to be sold to external users and software acquired in a business combination are amortized based on current and projected future revenue for each product with an annual minimum equal to the straight-line amortization over three years. Impairment of Long-Lived Assets Long lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount that the carrying amount of the asset exceeds the fair value of the asset. Goodwill Goodwill consists of the purchase price of business acquisitions in excess of the fair value of the net assets acquired. Goodwill is reviewed for impairment annually or when events or circumstances indicate that the carrying value of the reporting unit may exceed its fair value.If the carrying value of a reporting unit exceeds the fair value, an impairment loss will be recognized.The Company did not recognize any impairment charges for each of the years ended December 31, 2020 and 2019. We are required to test our goodwill for impairment at least annually, or more frequently if conditions indicate that an impairment may have occurred. Goodwill is tested for impairment at the asset level. Our reporting units are acquired companies at which discrete financial information may be available and for which operating results are regularly reviewed by our chief operating decision maker to allocate resources and assess performance. We have the option to qualitatively or quantitatively assess goodwill for impairment and, in 2020, we evaluated our goodwill using a qualitative assessment process. If the qualitative factors determine that it is more likely than not that the fair value of the reporting unit exceeds the carrying amount, goodwill is not impaired. If the qualitative assessment determines it is more likely than not the fair value is less than the carrying amount, we would further evaluate for potential impairment. As of December 31, 2020, we had $0.491 million of Goodwill on our balance sheet associated with two acquisitions, ICD Logic and TrinIT. ICD Logic related goodwill, which accounts for $0.361 million of the total Goodwill balance is the basis for the underlying technology associated with one of the Company’s faster growing and more promising SaaS offerings. TrinIT related Goodwill accounts for $0.130 million of the total Goodwill balance. The TrinIT acquisition was made in 2020 and is performing to expectations. During 2020, there were no indications of a triggering event at the 2 reporting units. The annual goodwill impairment analysis resulted in no indications of impairment in 2020 or 2019. We are subject to financial statement risk to the extent that our goodwill become impaired due to decreases in the fair value. A future decline in performance, decreases in projected growth rates or margin assumptions or changes in discount rates could result in a potential impairment, which could have a material adverse impact on our financial position and results of operations. Revenue Recognition We have 5 primary sources of revenue as of December 31, 2020: 1. Electronic Health Records (EHR/Practice Management) software 2. Encrypted and HIPAA Compliant Secure email 3. ICD Coding Software 4. ePrescription Software 5. IT Managed Services 1) Revenue from Practice Management software licensing arrangements are based on subscription basis using the software as a service (SaaS”) model with revenues recognized ratably over the contract term. 2) Encrypted HIPAA compliant secure email services are provided on an annual subscription basis using the software as a service (“SaaS”) model with revenues recognized ratably over the contract term. 3) ICD Coding Software provides the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO). It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases. ICD coding services are provided on a subscription basis using the software as a service (“SaaS”) model with revenues recognized ratably over the contract term.The length of the contract period varies from monthly to multiyear. 4) ePrescription software services are provided on an annual basis using the software as a service (‘SaaS’) model with revenue recognized ratably over the contract term. 5) Managed IT services – Consist of 3 revenue streams. (i)Monthly recurring “Managed Service Provider (MSP)” model, (ii) periodic sale and installation of IT related hardware, and (iii) ad hoc customer IT projects. The MSP model revenue is recognized monthly on a recurring basis while the revenue relating to IT hardware and ad hoc customer IT projects is recognized when the services are performed. On January 3, 2020, the Company purchased the assets of Computer Plumber, LLC, doing business as TrinIT (“TrinIT”), an IT service company located in the Charlotte, North Carolina area to complement our technology line up. TrinIT generates revenue primarily from their: 1) monthly recurring “Managed Service Provider (MSP)” model, 2) periodic sale and installation of IT related hardware, and 3) ad hoc customer IT projects.The MSP model revenue is recognized monthly on a recurring basis while the revenue relating to IT hardware and ad hoc customer IT projects is recognized when the services are performed.(See Note 13). We recognize revenue for our service in accordance with accounting standard ASC 606. Our customers are acquired through our own salesforce and through the referrals from our many state association marketing partners. We primarily generate revenue from multiple software as a service (SaaS) offerings, which typically include subscriptions to our online software solutions. The Company’s secondary source of revenue is professional services and other revenue related to customer onboarding, IT services and equipment sales that often precede a subscription service offering purchased by the customer. Approximately 80% of our revenue is subscription based with the remainder being professional services and other IT related revenue. The geographic concentration of our revenue is 100% in North America. Our customers do not have the right to take possession of the online software solution. Revenue from subscriptions, including additional fees for items such as incremental contacts, is recognized ratably over the subscription period beginning on the date the subscription is made available to customers. Substantially all subscription contracts are one year. We recognize revenue from on-boarding services and equipment as the services are provided. Amounts billed that have not yet met the applicable revenue recognition criteria are recorded as deferred revenue. Advertising Costs Advertising costs are reported in general and administrative expenses and include advertising, marketing and promotional programs and are charged as expenses in the year in which they are incurred. Advertising costs were $70,000 and $34,000 for the years ended December 31, 2020 and 2019, respectively. Accounting for Derivative Instruments The Company accounts for derivative instruments in accordance with ASC 815, which requires additional disclosures about the Company’s objectives and strategies for using derivative instruments, how the derivative instruments and related hedged items are accounted for, and how the derivative instruments and related hedging items affect the financial statements. The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risk. Terms of convertible debt and preferred stock instruments are reviewed to determine whether or not they contain embedded derivative instruments that are required under ASC 815 to be accounted for separately from the host contract and recorded on the balance sheet at fair value. The fair value of derivative liabilities, if any, is required to be revalued at each reporting date, with corresponding changes in fair value recorded in current period operating results. Freestanding warrants issued by the Company in connection with the issuance or sale of debt and equity instruments are considered to be derivative instruments. Pursuant to ASC 815, an evaluation of specifically identified conditions is made to determine whether the fair value of warrants issued is required to be classified as equity or as a derivative liability. Income Taxes The Company follows the asset and liability approach to accounting for income taxes. Under this method, deferred tax assets and liabilities are measured based on differences between the financial reporting and tax bases of assets and liabilities measured using enacted tax rates and laws that are expected to be in effect when differences are expected to reverse. Valuation allowances are established when it is necessary to reduce deferred income tax assets to the amount, if any, expected to be realized in future years. ASC 740, Accounting for Income taxes (“ASC 740”), requires that deferred tax assets be evaluated for future realization and reduced by a valuation allowance to the extent we believe a portion more likely than not will not be realized. We consider many factors when assessing the likelihood of future realization of our deferred tax assets, including our recent cumulative loss experience and expectations of future taxable income by taxing jurisdictions, the carry forwarding periods available to us for tax reporting purposes and other relevant factors. The Company has not recognized a liability for uncertain tax positions. A reconciliation of the beginning and ending amount of unrecognized tax benefits or penalties has not been provided since there has been no unrecognized benefit or penalty. If there were an unrecognized tax benefit or penalty, the Company would recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. The Company files U.S. Federal income tax returns and various returns in state jurisdictions. The Company's open tax years subject to examination by the Internal Revenue Service and the state Departments of Revenue generally remain open for three years from the date of filing. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and to the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates. Net Loss Per Share Basic net loss per share is computed by dividing net loss by the weighted average number of shares of Common Stock outstanding for the period. Diluted net loss per share reflects the potential dilution of securities by adding other Common Stock equivalents, including stock options, shares issuable on exercise of warrants, convertible preferred stock and convertible notes in the weighted average number of common shares outstanding for a period, if dilutive. Common stock equivalents that are anti-dilutive were excluded from the computation of diluted earnings per share which consisted of all outstanding common stock options and warrants. Stock-Based Compensation The Company uses the fair value method to account for the granting of options to purchase shares of its stock whereby all awards are recorded at fair value on the date of the grant. Share based awards with a performance condition are measured based on the probable outcome of that performance condition during the requisite service period. Such an award with a performance condition is accrued if it is probable that a performance condition will be achieved. Compensation costs for stock-based payments that do not include performance conditions are recognized on a straight-line basis. The fair value of all share purchase options is expensed over their requisite service period with a corresponding increase to additional capital surplus. Upon exercise of share purchase options, the consideration paid by the option holder, together with the amount previously recognized in additional capital surplus, is recorded as an increase to share capital. The Company estimates the fair value of each option award on the date of grant using a Black-Scholes option pricing model that uses the assumptions noted in the table below. The Company estimates the fair value of its common stock using the closing stock price of its common stock on the option grant date. The Company estimates the volatility of its common stock at the date of grant based on its historical stock prices. The Company uses the risk-free interest rate on the implied yield currently available on U.S. Treasury issues with an equivalent remaining term approximately equal to the expected life of the award. The Company has never paid any cash dividends on its common stock and does not anticipate paying any cash dividends in the foreseeable future. The fair value of shares of restricted stock issued are determined by the Company based on the estimated fair value of the Company’s common stock. Recently Issued Accounting Pronouncements In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), The Company does not believe that any other issued, but not yet effective accounting standards, if currently adopted, will have a material effect on the Company’s consolidated financial position, results of operations and cash flows. Going Concern The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business. For the fiscal year period ended Dec 31, 2020, the Company generated an operating loss of $3,491,241. In addition, the Company has an accumulated deficit, total stockholders’ deficit and net working capital deficit of $77,831,081, $628,940 and $3,031,001 at Dec 31, 2020, respectively. The Company’s activities were primarily financed through private placements of equity securities. The Company intends to raise additional capital through the issuance of debt and/or equity securities to fund its operations. The Company is reliant on future fundraising to finance operations in the near future. The financing may not be available on terms satisfactory to the Company, if at all. In light of these matters, there is substantial doubt that the Company will be able to continue as a going concern. Currently, management intends to develop a vastly improved healthcare communications system and intends to develop alliances with strategic partners to generate revenues that will sustain the Company. While management believes in the viability of its strategy to increase revenues and in its ability to raise additional funds, there can be no assurances to that effect. Management’s ability to continue as a going concern is ultimately dependent upon its ability to continually increase the Company’s customer base and realize increased revenues from signed contracts. The financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

COMMON STOCK

COMMON STOCK	12 Months Ended
	Dec. 31, 2020
COMMON STOCK
Note 3 - COMMON STOCK	Stock Issuances During the year ended December 31, 2020, the Company issued 7,128,002 shares of common stock for cash of $1,040,000. The Company issued 6,761,558 shares of common stock for the conversion of notes payable of $201,600. The Company issued 730,000 shares of common stock for the acquisition of TrinIT (Note 8). The Company also issued 4,555,994 shares of common stock to acquire technology and certain other assets of ClariCare Inc. (See Note 12) in accordance with the asset purchase agreement. The Company issued 1,000,000 shares of common stock for the conversion accounts payable of $250,781. The Company issued 250,000 shares of common stock for a commitment fee on note of $37,500. The Company issued 2,124,693 shares of common stock for stock compensation expense of $423,300. The Company issued 50,000 shares of common stock for an origination fee for a convertible debt agreement for $4,500. The Company issued 5,000 shares of common stock for the exercise of stock options of $1,000. During the year ended December 31, 2019, the Company issued 12,435,759 shares of common stock for cash and conversion of notes payable proceeds totaling $3,217,000. The Company also issued 2,301,007 shares of common stock to acquire technology and certain other assets of ClariCare Inc. (See Note 12). The Company also issued 66,666 shares of common stock as compensation to a former employee for services performed. The Company authorized 675,000 shares of restricted stock as compensation to certain executives and directors for services performed, of which 412,500 shares vested and were issued in 2019 with the remaining 262,500 shares vesting evenly in 2020 and 2021. Lastly, the Company issued 1,396,026 shares of restricted stock during 2019 related to the vesting of prior year restricted stock grants. Stock Options Certain employees and executives have been granted options or warrants that are compensatory in nature. A summary of option activity for the year ended December 31, 2020 and 2019 are presented below: 2019 Options Outstanding Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term in Years Aggregate Intrinsic Value Balance Outstanding - January 1, 2018 198,402 $ 10.40 0.7 $ - Granted 1,300,000 $ 0.25 10.2 Exercised - Forfeited/expired (142,245 ) $ 9.05 Balance Outstanding - December 31, 2018 1,356,157 $ 0.31 9.8 $ - Exercisable - December 31, 2018 489,490 $ 0.29 9.1 $ - Balance Outstanding - January 1, 2019 1,356,157 $ 0.31 9.8 $ - Granted 135,000 $ 0.15 9.2 Exercised - Forfeited (81,157 ) $ 1.17 Balance Outstanding - December 31, 2019 1,410,000 $ 0.24 9.2 $ - Exercisable - December 31, 2019 976,667 $ 0.24 9.2 $ - 2019 Nonvested Options Number of Options Weighted Average Grant Date Fair Value Weighted Average Remaining Y ears to Vest Nonvested - January 1, 2018 18,719 $ 10.40 0.7 Granted 1,300,000 $ 0.13 Vested (452,052 ) $ 0.31 Forfeited/expired - Nonvested - December 31, 2018 866,667 $ 0.13 1.6 Nonvested - January 1, 2019 866,667 $ 0.13 1.6 Granted 135,000 $ 0.15 Vested (568,334 ) $ 0.13 Forfeited/expired - Nonvested - December 31, 2019 433,333 $ 0.13 0.6 2020 Options Outstanding Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term in Years Aggregate Intrinsic Value Balance Outstanding - January 1, 2020 1,410,000 $ 0.24 8.7 $ - Granted - $ - Exercised (5,000 ) $ 0.15 Forfeited - $ - Balance Outstanding - December 31, 2020 1,405,000 $ 0.24 7.7 $ - Exercisable - December 31, 2020 1,405,000 $ 0.24 7.7 $ - 2020 Nonvested Options Number of Options Weighted Average Grant Date Fair Value Weighted Average Remaining Years to Vest Nonvested - January 1, 2020 433,333 $ 0.13 0.6 Granted - $ - Vested (433,333 ) $ 0.13 Forfeited/expired - Nonvested - December 31, 2020 - $ - 0.00 Restricted Stock Compensation On April 13, 2020, the Company’s Board of Directors approved the grant of 250,000 restricted share of common stock to Directors of the Company, for services to be rendered during 2020, all of which vested on December 31, 2020. Compensation expense related to this grant for the year 2020 was $50,000 based upon fair value of our common stock of $.25 per share. On February 21, 2019, the Company’s Board of Directors approved the grant of 200,000 restricted shares of common stock to Directors of the Company, for services to be rendered during 2019, all of which shares vested on December 31, 2019. Compensation expense related to this grant for the year 2019 was $50,000 based upon the estimated fair value of our common stock of $0.25 per share. On February 21, 2019, the Company’s Board of Directors approved the grant of 475,000 restricted shares of common stock to management, for services rendered, of which 212,500 shares vested on the date of the Board of Director approval, with 131,250 shares vesting on each of the next two anniversary dates of the Board of Director approval. The total unvested restricted stock of 262,500 shares has been excluded from the shares of common stock outstanding on December 31, 2019 in the accompanying financial statements due to the restrictions on the shares.Compensation expense related to this grant for the year 2019 was approximately $81,000 based upon the estimated fair value of our common stock of $0.25 per share.Compensation expense of approximately $33,000 and $5,000 will be recognized related to this grant for each of the years 2020 and 2021, respectively. Compensation expense related to this planned grant for the year 2019 was $250,000 based upon the estimated fair value of our common stock of $0.25 per share, the offset to which is included in accrued expenses in the 2019 Consolidated Balance Sheets. On April 1, 2018, the Company reached an agreement with a Director of the Company, to issue 1,000,000 shares of restricted common stock as compensation for past services including securities offerings, financings, special projects and other matters similar in nature of which 333,333 shares vested upon issuance and 666,667 shares will vest evenly in 2019 and 2020. The total unvested restricted stock of 333,334 shares has been excluded from the shares of common stock outstanding on December 31, 2019 in the accompanying financial statements due to the restrictions on the shares. Compensation expense related to this grant for the year 2019 was approximately $83,000 based upon the estimated fair value of our common stock of $0.25 per share. Compensation expense related to this grant of approximately $31,000 was recognized in 2020. On May 22, 2018, the Company’s Board of Directors approved the grant of 4,287,161 shares of restricted common stock to management, for services rendered, of which 2,858,107 shares vested upon issuance and 1,429,054 shares vest evenly in 2019 and 2020. The total unvested restricted stock as of December 31, 2019 of 714,527 shares has been excluded from the shares of common stock outstanding on December 31, 2019 in the accompanying financial statements due to the restrictions on the shares. Compensation expense related to this grant for the year 2019 was approximately $179,000 based upon the estimated fair value of our common stock of $0.25 per share. Compensation expense related to this grant of approximately $67,000 was recognized in 2020. Warrants During the year ended December 31, 2019, the Company issued 55,000 warrants related to subscriptions of common stock which warrants have an exercise price of $1.35 per share and will expire on December 31, 2020. During the year ended December 31, 2019, none of these warrants expired or were exercised. During the year ended December 31, 2018, the Company issued 4,002,646 warrants related to subscriptions of common stock which warrants have an exercise price of $1.35 per share and will expire on December 31, 2020. During the year ended December 31, 2018, 72,669 warrants expired, and none were exercised. All outstanding warrants expired on December 31, 2020 with none being exercised.

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT	12 Months Ended
	Dec. 31, 2020
PROPERTY AND EQUIPMENT
Note 4 - PROPERTY AND EQUIPMENT	Property and equipment is stated at cost and consist of the following: December 31, December 31, 2020 2019 Furniture and fixtures $ 7,740 $ 8,000 Leasehold improvements 26,145 26,000 Equipment 16,439 16,000 $ 50,324 $ 50,000 Less accumulated depreciation (47,919 ) (44,000 ) $ 2,405 $ 6,000 Depreciation expense on property and equipment for the years ended December 31, 2020 and 2019, were $6,595 and $5,000, respectively.

SOFTWARE DEVELOPMENT COSTS

SOFTWARE DEVELOPMENT COSTS	12 Months Ended
	Dec. 31, 2020
SOFTWARE DEVELOPMENT COSTS
Note 5 - SOFTWARE DEVELOPMENT COSTS	A summary of the capitalization and amortization of software development costs as of the dates indicated follows: December 31, December 31, 2020 2019 Development costs $ 2,479,137 $ 1,936,000 Acquired technology 1,527,186 1,277,000 Less accumulated amortization (2,483,622 ) (1,697,000 ) $ 1,522,701 $ 1,516,000 Amortization of software development costs and acquired technology for the years ended December 31, 2020 and 2019, were $899,000 and $628,000, respectively.

LONG TERM DEBT

LONG TERM DEBT	12 Months Ended
	Dec. 31, 2020
LONG TERM DEBT
Note 6 - LONG TERM DEBT	December 31 December 31 2019 2020 (1) Note payable bearing interest at 12.0% per annum, due December 31, 2020 $ 118,000 $ 118,000 (2) Related Party Long term debt bearing interest at 8%, due April 15, 2021 100,257 92,602 (3) Related Party Promissory note bearing interest at 18%, due December 31, 2020 535,021 556,331 (4) Convertible note bearing interest at 10%, due July 15, 2021 156,438 81,018 (5) Convertible note bearing interest at 10%, due March 2, 2021 189,444 - (6) Convertible note bearing interest at 10%, due December 16, 2020 - 45,184 1,099,160 893,135 Less current maturities (1,099,160 ) (880,579 ) Total Long-term debt $ - $ 12,556 Total future minimum payments due on long-term debt as of December 31, 2020: 2021 1,099,160 2022 - 1,099,160 Our notes payable (including accrued interest) are summarized as follows: 1. The Company issued a note payable to a related party on December 31, 2018 with a principal amount of $100,000 bearing interest at a rate of 12% per annum, with quarterly accrued interest payments and with a balloon payment due by the maturity date of December 31, 2019. The balloon payment due on December 31, 2019 was not made and the Company issued, in exchange for the original note, a new note dated December 31, 2019 with a principal amount of $100,000 bearing interest at a rate of 12% per annum, with quarterly accrued interest payments and a balloon payment due on the maturity date of December 31, 2020.The amounts owing on the note as of December 31, 2019 were $100,000 of principal plus $18,000 of accrued interest. In January of 2021, $136,000 of principal and accrued interest was converted into 2,720,000 shares of Common Stock. 2. The Company issued a note payable to a related party on December 31, 2018 with a principal amount of $714,000, bearing interest at a rate of 18% per annum, with monthly principal and accrued interest payments and with a balloon payment due by the maturity date of December 31, 2019. The balloon payment due on December 31, 2019 was not made and the Company issued, in exchange for the original note, a new note dated December 31, 2019 with a principal amount of $556,000, bearing interest at a rate of 18% per annum, with monthly principal and accrued interest payments and a balloon payment due by the maturity date of December 31, 2020.The amounts owing on the note as of December 31, 2019 were $556,000 of principal plus a nominal amount of accrued interest.As of December 31, 2020, $535,021 of principal was outstanding on this note payable. Subsequent to the end of fiscal 2020, the maturity on note payable to the related party was extended to a new 2-year term note payable bearing interest rate payable of 18% per annum with a maturity date of December 31, 2023. The note will pay monthly cash interest only in the first year (12 months) of note payable term. In the 2nd year, the note payable will be repaid with 12 monthly installment payments of interest and principal until fully repaid. 3. In August 2019, the Company signed a $78,000 convertible promissory note payable to a finance company due twelve months after issuance and received $75,000 net of closing fees. Interest at 10% per annum not due until maturity.The amounts owing on the convertible note as of December 31, 2019 were $78,000 in principal with accrued interest of $3,000.One hundred eighty (180) days following the date of funding and thereafter, the note was convertible into common stock of the Company ("Common Stock"). The conversion price of the Note was 61% of the Market Price (as defined in the Note) for the Common Stock (a discount of 39%). The conversion price was determined on the basis of the average of the three (3) lowest closing bid prices for the Common Stock during the prior fifteen (15) trading day period. There was an ascending prepayment penalty percentage applied should the Company prepay the note during the first one hundred eighty (180) days after which the Company had no right of prepayment.The note holder was limited to receive upon conversion no more than 4.99% of the issued and outstanding Common Stock at the time of conversion at any one time. This convertible promissory note was converted in full in 2020. 4. In December 2019, the Company signed a $45,000 convertible promissory note payable to a second finance company due twelve (12) months after issuance and received $40,000 net of closing fees. Interest at 10% per annum is not due until maturity.The amounts owing on the convertible note as of December 31, 2019 were $45,000 of principal and a nominal amount of accrued interest.One hundred eighty (180) days following the date of funding and thereafter, the note was convertible into common stock of the Company ("Common Stock"). The conversion price of the Note was 61% of the Market Price (as defined in the Note) for the Common Stock (a discount of 39%). The conversion price was determined on the basis of the lowest traded price for the Common Stock during the prior twenty (20) trading day period. There was an ascending prepayment penalty percentage applied should the Company prepay the note during the first one hundred eighty (180) days after which the Company had no right of prepayment.The note holder was limited to receive upon conversion no more than 4.99% of the issued and outstanding Common Stock at the time of conversion at any one time. This convertible promissory note was paid off in December of 2020.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2020
INCOME TAXES
Note 7 - INCOME TAXES	The Company has incurred net losses since inception. As of December 31, 2019, the Company had cumulative federal net operating loss carryforwards of approximately $9,924,000 which are available to be carried forward indefinitely and federal net operating loss carryforwards of approximately $55,276,000 which at the latter date may be carried forward for tax years ending through December 31, 2037. Utilization of NOL carryforwards may be limited under various sections of the Internal Revenue Code depending on the nature of the Company’s operations. The Company’s income tax returns are subject to examination by the Internal Revenue Service and applicable state taxing authorities, generally for a period of three years from the date of filing. Deferred taxes comprise the following as of December 31, 2020 and 2019: 2020 2019 Deferred Income Tax Assets 13,692,000 13,327,000 Valuation Allowance (13,692,000 ) (13,327,000 ) Net Deferred Tax Asset - - Reconciliation of the effective income tax rate to the federal statutory rate: Federal Income Tax Rate 21 % 21 % Change in valuation allowance including the effect of the rate change -21 % -21 % Effective income tax rate 0 % 0 %

CONCENTRATION OF CREDIT RISK

CONCENTRATION OF CREDIT RISK	12 Months Ended
	Dec. 31, 2020
CONCENTRATION OF CREDIT RISK
Note 8 - CONCENTRATION OF CREDIT RISK	The Company has historically provided financial terms to customers in accordance with what management views as industry norms. Access to the Company’s software products usually requires immediate payment but can extend several months under certain circumstances. Management periodically and regularly reviews customer account activity in order to assess the adequacy of allowances for doubtful accounts, considering such factors as economic conditions and each customer’s payment history and creditworthiness. If the financial condition of our customers were to deteriorate, or if they were otherwise unable to make payments in accordance with management’s expectations, we might have to increase our allowance for doubtful accounts, modify their financial terms and/or pursue alternative collection methods. The company has one significant customer (greater than 10% of total revenue) that represented 13% of 2020 revenue. The significant customer’s share of total revenue is down from 21% from 2019 due to organic growth of other customers and the acquisition of TrinIT that further diversified the Company’s customer concentration. The company has accounts receivable concentration with two customers that represent 21% and 16% of our accounts receivable.Overall, the company grew its accounts receivable approximately ending balance 25% in 2020 from year-end 2019, compared to an over 100% growth in sales for 2020. Day’s sales outstanding was less than 30 days at fiscal year-end 2020.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2020
COMMITMENTS AND CONTINGENCIES
Note 9 - COMMITMENTS AND CONTINGENCIES	(A) LEASE COMMITMENTS On November 15, 2017, the Company signed a three-year lease agreement for approximately 4,100 square feet of office space located in Winter Garden, Florida in which the Company has its headquarters. The lease provided for a one-year renewal term at the option of the Company that the company exercised. An amendment to this lease was signed on October 26, 2020 which extended the lease term through October 31, 2021. As of December 31, 2020, undiscounted future lease obligations for the office space are $68,000 for the year ended December 31, 2020. On January 1, 2019, the Company adopted ASU 2016-02, Leases (Topic 842), iCoreConnect Lease Commitments as of 12/31/2020 Less than 1 year 1-3 years 3-5 years Total $ 100,114 $ 68,000 $ - $ 168,114 Lease costs for the year ended December 31, 2020 were $123,500 and cash paid for amounts included in the measurement of lease liabilities for the year ended December 31, 2019 were $57,000.As of December 31, 2020, the following represents the difference between the remaining undiscounted lease commitments under non-cancelable leases and the lease liabilities: Undiscounted minimum lease commitments $ 168,114 Present value adjustment using incremental borrowing rate (17,637 ) Lease liabilities $ 150,477 (B) EMPLOYMENT AGREEMENTS WITH NAMED EXECUTIVE OFFICERS On July 1, 2018, Robert McDermott, the President and Chief Executive Officer of the Company, entered into an employment agreement with the Company pursuant to which the Company employed Mr. McDermott for a term of three years and six months. Mr. McDermott received a starting annual base salary of $250,000 per annum which increased to $262,500 per annum on July 1, 2019 and will increase to $275,500 per annum on July 1, 2020 and $289,000 per annum on July 1, 2021. In addition, Mr. McDermott is eligible to receive incentive bonus compensation pursuant to an executive bonus plan approved by the Board of Directors or the Compensation Committee of the Board of Directors. For the year ended December 31, 2018 Mr. McDermott received a bonus of 350,000 restricted shares and for the year ended December 31, 2019 he received a cash bonus of $75,000 and the Company planned to award him 800,000 restricted shares in early 2020 which has been reflected as compensation expense in the accompanying 2019 Consolidated Statements of Operations. Also, Mr. McDermott was awarded an option to purchase 700,000 shares of the Company’s Common Stock of which 33% (233,333 shares) vested on July 1, 2018, another 33% (233,333 shares) vested on July 1, 2019 and the remaining 33% (233,334 shares) vested on July 1, 2020. In the event of termination of Mr. McDermott’s employment due to a change in control, by reason of his death or disability or by the Company without cause, his stock options that have not already vested will fully vest on the date of termination and any restrictions on any restricted stock owned by Mr. McDermott shall be lifted. Further, in the event of the termination of Mr. McDermott’s employment (i) due to a change in control Mr. McDermott will continue to receive his base salary and his annual bonus computed at 100% of his base salary for the 24 month period following the date of termination, (ii) due to death or disability Mr. McDermott or his estate will continue to receive his base salary during the six month period following the date of termination and (iii) by the Company without cause Mr. McDermott will continue to receive his base salary for the 18 month period following the date of termination or through the end of the employment period, whichever is longer. On October 1, 2018, David Fidanza, the Chief Information Officer of the Company, entered into an employment agreement with the Company, pursuant to which the Company employed Mr. Fidanza for a term of three years. Mr. Fidanza received a starting annual base salary of $115,000 per annum which increased to $125,000 per annum on October 1, 2019 and to $130,000 per annum on October 1, 2020. Also, Mr. Fidanza was awarded an option to purchase 300,000 shares of the Company’s Common Stock. 33% of the option award (100,000 shares) vested on October 1, 2018, another 33% (100,000 shares) vested on October 1, 2019 and the remaining 33% (100,000 shares) vested on October 1, 2020. In the event of termination of Mr. Fidanza’s employment due to a change in control, by reason of his death or disability or by the Company without cause, the stock option will become fully vested on the date of termination and any restrictions on any restricted stock owned by Mr. Fidanza shall be lifted. Further, in the event of the termination of Mr. Fidanza’s employment (i) due to a change in control Mr. Fidanza will continue to receive his base salary and his annual bonus computed at 100% of his base salary for the six month period following the date of termination, (ii) due to death or disability Mr. Fidanza or his estate will continue to receive his base salary during the six month period following the date of termination and (iii) by the Company without cause Mr. Fidanza will continue to receive his base salary for the six month period following the date of termination or through the end of the employment period, whichever is longer. On November 1, 2018, Murali Chakravarthi, the Chief Technology Officer of the Company, entered into an employment agreement with the Company, pursuant to which the Company employed Mr. Chakravarthi for three years. Mr. Chakravarthi is to receive an annual base salary of $120,000. Also, Mr. Chakravarthi was awarded an option to purchase 300,000 shares of the Company’s Common Stock. 33% of the option award (100,000 shares) vested on November 1, 2018, another 33% (100,000 shares) vested on November 1, 2019 and the remaining 33% (100,000 shares) vested on November 1, 2020. In the event of termination of Mr. Chakravarthi’s employment due to a change in control, by reason of his death or disability or by the Company without cause, the stock option will become fully vested on the date of termination and any restrictions on any restricted stock owned by Mr. Chakravarthi shall be lifted.Further, in the event of the termination of Mr. Chakravarthi’s employment (i) due to a change in control Mr. Chakravarthi will continue to receive his base salary and his annual bonus computed at 100% of his base salary for the six month period following the date of termination, (ii) due to death or disability Mr. Chakravarthi or his estate will continue to receive his base salary during the six month period following the date of termination and (iii) by the Company without cause Mr. Chakravarthi will continue to receive his base salary for the six month period following the date of termination or through the end of the employment period, whichever is longer. (C) LITIGATION From time to time, the Company may become involved in various lawsuits and legal proceedings that arise in the ordinary course of business. Litigation is, however, subjective to inherent uncertainties and an adverse result in these or other matters may harm the Company’s business. The Company is not aware of any legal proceedings or claims that it believes would or could have, individually or in the aggregate, a material adverse effect on its operations or financial position.

BUSINESS COMBINATIONS

BUSINESS COMBINATIONS	12 Months Ended
	Dec. 31, 2020
BUSINESS COMBINATIONS
Note 10 - BUSINESS COMBINATIONS	ClariCare Inc. On April 30, 2019 iCoreConnect Inc., acquired technology and certain other assets of ClariCare Inc., an Indiana corporation, in exchange for (i) $50,000 in cash, (ii) 2,301,007 shares of the Company’s common stock, subject to adjustment, and (iii) the assumption of certain specified liabilities including a company credit card balance not to exceed $23,000, all upon the terms and conditions set forth in the Asset Purchase Agreement dated as of April 30, 2019 (the “ClariCare Asset Purchase Agreement”) which was attached as an exhibit to the Company’s Form 8-K filed on May 2, 2019 with the SEC. The Company was required to issue additional shares on September 30, 2020 if the stock price is less than $1.49 per share as of that date. The company issued 4,555,974 shares of Common Stock on September 30, 2020 to complete the requirements of the ClariCare Asset Purchase Agreement. This resulted in an increase in the asset of $250,580. ClariCare created cloud-based dental analytics and practice management software to provide dentists and providers to the dental market modern tools to run their practices more efficiently and effectively and which are a complement to our current dental market product offerings. The Company accounted for the acquisition of the ClariCare business and assets as an asset acquisition under ASC 805, which provides guidance for asset acquisitions. Under the guidance, if substantially all of the acquisition is made up of one asset or similar assets, then the acquisition is an asset acquisition. The Company believes the assets acquired from ClariCare are similar and consider them all to be acquired technology (See Note 6).Further, the Company does not believe the acquired technology constitutes a business as defined under ASC 805. TrinIT On January 3, 2020 the Company acquired substantially all of the assets and business of Computer Plumber, LLC, a North Carolina limited liability company doing business as TrinIT (“Seller”), in exchange for (i) 730,000 shares of Common Stock of Buyer, (ii) $400,000 in cash, and (iii) the assumption of certain specified debts, liabilities and obligations, all upon the terms and conditions set forth in an Asset Purchase Agreement dated as of January 3, 2020 (the “Computer Plumber LLC Asset Purchase Agreement”). Pursuant to the guidance in FASB Accounting Standards Codification (“ASC”) Topic 805, Business Combinations, the Company calculated the estimated fair value of the acquired customer relationships using the discounted cash flow approach. The key assumptions and inputs into the cash flow model used were: (1) an annual customer attrition rate of 8%, (2) a gross margin percentage of 55%, (3) a tax rate of 23.50% and (4) a discount rate of 12%. Certain fair values of the acquired assets and assumed liabilities may be estimated at the acquisition date pending confirmation or completion of the valuation process. Where provisional values are used in accounting for a business combination, they may be adjusted retrospectively in subsequent periods within the measurement period when it reflects new information obtained about facts and circumstances that were in existence at the acquisition date. The measurement period cannot exceed one year from the acquisition date. The following table summarizes the consideration paid and the fair value of the assets acquired and liabilities assumed as of January 3, 2020: Consideration Paid: Cash $ 400,000 Common stock 183,000 $ 583,000 Fair values of identifiable assets acquired and liabilities assumed: Assets acquired: Cash $ 25,000 Other current asset 6,000 Right of Use - Lease 14,000 Fixed Assets 3,000 Customer relationships 450,000 Total assets acquired 498,000 Liabilities assumed: Due to Seller 10,000 Accrued Liability 15,000 Deferred revenue 6,000 Lease Liability 14,000 Total liabilities assumed 45,000 Net assets acquired $ 453,000 Goodwill $ 130,000

PRO FORMA FINANCIAL STATEMENTS

PRO FORMA FINANCIAL STATEMENTS	12 Months Ended
	Dec. 31, 2020
PRO FORMA FINANCIAL STATEMENTS
Note 11 - PRO FORMA FINANCIAL STATEMENTS	None.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2020
SUBSEQUENT EVENTS
Note 12 - SUBSEQUENT EVENTS	In December of 2020, the Company paid off a note from a finance company in the amount of $61,764. In January of 2021, the Company paid off a note from a second finance company of $150,309.In January of 2021, the Company paid off a note from a third finance company in the amount of $135,520. In March of 2021, the Company paid off a different note from the third finance company in the amount of $135,520. In January of 2021, the Company and a finance company entered into a Purchase Agreement between the Company and an Investor (the “Investor”). The Company executed a Registration Rights Agreement (the “Registration Rights Agreement”), and a Securities Purchase Agreement (the “SPA”) with the Investor. Pursuant to the Purchase Agreement, the Investor committed to purchase, subject to certain restrictions and conditions, up to $5.0 million worth (the “Commitment”) of the Company’s common stock over a period of 24 months from the effectiveness of the registration statement registering for resale shares purchased by the Investor pursuant to the Purchase Agreement. In addition, the Company has issued 250,000 restricted shares of its common stock (the “Commitment Shares”) to the Investor as a commitment fee. The Purchase Agreement provides that at any time after the effective date of the Registration Statement, from time to time on any business day selected by the Company, the Company shall have the right, but not the obligation, to direct the Investor to buy the lesser of $250,000 or 300% of the average shares traded for the 10 days prior to the closing request date, at a purchase price of 75% of the lowest daily traded VWAP price during the five trading days preceding the draw down or put notice, with a minimum purchase price request of $25,000. The payment for the shares covered by each request notice will occur on the business day the Investor receives the trade settlement for the purchased shares. In addition, the Investor will not be obligated to purchase shares if the total number of shares beneficially owned by the Investor or an affiliate of the Investor at that time would exceed 9.99% of the number of shares of the Company’s common stock as determined in accordance with Rule 13d-3 of the Securities Exchange Act of 1934, as amended. In addition, the Company is not permitted to draw on the facility unless there is an effective registration statement to cover the resale of the shares. In January of 2021, executives and employees converted notes payable and services rendered of $819,000 into approximately 16.4 million shares of Common Stock. In the first quarter of 2021, the Company issued approximately 23 million shares of Common stock for $1.1 million in cash. In January of 2021, the Company and a finance company entered into a Purchase Agreement between the Company and an Investor (the “Investor”). The Purchase Agreement is an equity line of credit and the Investor committed to purchase, subject to certain restrictions and conditions, up to $5.0 million worth (the “Commitment”) of the Company’s common stock over a period of 24 months from the effectiveness of the registration statement registering for resale shares purchased by the Investor pursuant to the Purchase Agreement.See Subsequent Events (Section 14).The Company has no other lines of credit as of March 27, 2021.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation and Principles of Consolidations	The accompanying consolidated financial statements are presented in United States dollars and include the accounts of the Company’s wholly owned subsidiaries, with all intercompany transactions eliminated. They have been prepared on the accrual basis in accordance with accounting principles generally accepted in the United States (GAAP).Significant accounting principles followed by the Company and the methods of applying those principles, which materially affect the determination of financial position, results of operations and cash flows are summarized below.
Fair Value of Financial Instruments	The Company measures certain financial assets at fair value. Fair value is determined based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, as determined by either the principal market or the most advantageous market. Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy, as follows: Level 1 — Quoted prices in active markets for identical assets or liabilities. Level 2 — Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 — Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.
Cash and Cash Equivalents	The Company classifies highly liquid temporary investments with an original maturity of three months or less when purchased as cash equivalents. The Company maintains cash balances at various financial institutions. Balances at United States banks are insured by the Federal Deposit Insurance Corporation up to $250,000. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risk for cash on deposit.
Accounts Receivable and Allowance for Doubtful Accounts	Accounts receivable are customer obligations due under normal trade terms. We maintain an allowance for doubtful accounts for estimated losses resulting from the potential inability of certain customers to make required future payments on amounts due us. Management determines the adequacy of this allowance by periodically evaluating the aging and past due nature of individual customer accounts receivable balances and considering the customer’s current financial situation as well as the existing industry economic conditions and other relevant factors that would be useful in assessing the risk of collectability. If the future financial condition of our customers were to deteriorate, resulting in their inability to make specific required payments, additions to the allowance for doubtful accounts may be required. In addition, if the financial condition of our customers improves and collections of amounts outstanding commence or are reasonably assured, then we may reverse previously established allowances for doubtful accounts. The Company has estimated and recorded an allowance for doubtful accounts of $77,000 and $17,000 as of December 31, 2020 and 2019, respectively.
Property, Equipment and Depreciation	Property, equipment, and leasehold improvements are recorded at their historical cost. Depreciation and amortization have been determined using the straight-line method over the estimated useful lives of the assets which are computers and office equipment (3 years) and for office furniture and fixtures (7 years). The cost of repairs and maintenance is charged to operations in the period incurred.
Software Development Costs and Acquired Software	The Company accounts for software development costs, including costs to develop software products or the software component of products to be sold to external users. In accordance with ASC 985-730, Computer Software Research and Development, research and planning phase costs are expensed as incurred and development phase costs including direct materials and services, payroll and benefits and interest costs are capitalized. We have determined that technological feasibility for our products to be marketed to external users was reached before the release of those products. As a result, the development costs and related acquisition costs after the establishment of technological feasibility were capitalized as incurred. Capitalized costs for software to be sold to external users and software acquired in a business combination are amortized based on current and projected future revenue for each product with an annual minimum equal to the straight-line amortization over three years.
Impairment of Long-Lived Assets	Long lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount that the carrying amount of the asset exceeds the fair value of the asset.
Goodwill	Goodwill consists of the purchase price of business acquisitions in excess of the fair value of the net assets acquired. Goodwill is reviewed for impairment annually or when events or circumstances indicate that the carrying value of the reporting unit may exceed its fair value.If the carrying value of a reporting unit exceeds the fair value, an impairment loss will be recognized.The Company did not recognize any impairment charges for each of the years ended December 31, 2020 and 2019. We are required to test our goodwill for impairment at least annually, or more frequently if conditions indicate that an impairment may have occurred. Goodwill is tested for impairment at the asset level. Our reporting units are acquired companies at which discrete financial information may be available and for which operating results are regularly reviewed by our chief operating decision maker to allocate resources and assess performance. We have the option to qualitatively or quantitatively assess goodwill for impairment and, in 2020, we evaluated our goodwill using a qualitative assessment process. If the qualitative factors determine that it is more likely than not that the fair value of the reporting unit exceeds the carrying amount, goodwill is not impaired. If the qualitative assessment determines it is more likely than not the fair value is less than the carrying amount, we would further evaluate for potential impairment. As of December 31, 2020, we had $0.491 million of Goodwill on our balance sheet associated with two acquisitions, ICD Logic and TrinIT. ICD Logic related goodwill, which accounts for $0.361 million of the total Goodwill balance is the basis for the underlying technology associated with one of the Company’s faster growing and more promising SaaS offerings. TrinIT related Goodwill accounts for $0.130 million of the total Goodwill balance. The TrinIT acquisition was made in 2020 and is performing to expectations. During 2020, there were no indications of a triggering event at the 2 reporting units. The annual goodwill impairment analysis resulted in no indications of impairment in 2020 or 2019. We are subject to financial statement risk to the extent that our goodwill become impaired due to decreases in the fair value. A future decline in performance, decreases in projected growth rates or margin assumptions or changes in discount rates could result in a potential impairment, which could have a material adverse impact on our financial position and results of operations.
Revenue Recognition	We have 5 primary sources of revenue as of December 31, 2020: 1. Electronic Health Records (EHR/Practice Management) software 2. Encrypted and HIPAA Compliant Secure email 3. ICD Coding Software 4. ePrescription Software 5. IT Managed Services 1) Revenue from Practice Management software licensing arrangements are based on subscription basis using the software as a service (SaaS”) model with revenues recognized ratably over the contract term. 2) Encrypted HIPAA compliant secure email services are provided on an annual subscription basis using the software as a service (“SaaS”) model with revenues recognized ratably over the contract term. 3) ICD Coding Software provides the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO). It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases. ICD coding services are provided on a subscription basis using the software as a service (“SaaS”) model with revenues recognized ratably over the contract term.The length of the contract period varies from monthly to multiyear. 4) ePrescription software services are provided on an annual basis using the software as a service (‘SaaS’) model with revenue recognized ratably over the contract term. 5) Managed IT services – Consist of 3 revenue streams. (i)Monthly recurring “Managed Service Provider (MSP)” model, (ii) periodic sale and installation of IT related hardware, and (iii) ad hoc customer IT projects. The MSP model revenue is recognized monthly on a recurring basis while the revenue relating to IT hardware and ad hoc customer IT projects is recognized when the services are performed. On January 3, 2020, the Company purchased the assets of Computer Plumber, LLC, doing business as TrinIT (“TrinIT”), an IT service company located in the Charlotte, North Carolina area to complement our technology line up. TrinIT generates revenue primarily from their: 1) monthly recurring “Managed Service Provider (MSP)” model, 2) periodic sale and installation of IT related hardware, and 3) ad hoc customer IT projects.The MSP model revenue is recognized monthly on a recurring basis while the revenue relating to IT hardware and ad hoc customer IT projects is recognized when the services are performed.(See Note 13). We recognize revenue for our service in accordance with accounting standard ASC 606. Our customers are acquired through our own salesforce and through the referrals from our many state association marketing partners. We primarily generate revenue from multiple software as a service (SaaS) offerings, which typically include subscriptions to our online software solutions. The Company’s secondary source of revenue is professional services and other revenue related to customer onboarding, IT services and equipment sales that often precede a subscription service offering purchased by the customer. Approximately 80% of our revenue is subscription based with the remainder being professional services and other IT related revenue. The geographic concentration of our revenue is 100% in North America. Our customers do not have the right to take possession of the online software solution. Revenue from subscriptions, including additional fees for items such as incremental contacts, is recognized ratably over the subscription period beginning on the date the subscription is made available to customers. Substantially all subscription contracts are one year. We recognize revenue from on-boarding services and equipment as the services are provided. Amounts billed that have not yet met the applicable revenue recognition criteria are recorded as deferred revenue.
Advertising Costs	Advertising costs are reported in general and administrative expenses and include advertising, marketing and promotional programs and are charged as expenses in the year in which they are incurred. Advertising costs were $70,000 and $34,000 for the years ended December 31, 2020 and 2019, respectively.
Accounting for Derivative Instruments	The Company accounts for derivative instruments in accordance with ASC 815, which requires additional disclosures about the Company’s objectives and strategies for using derivative instruments, how the derivative instruments and related hedged items are accounted for, and how the derivative instruments and related hedging items affect the financial statements. The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risk. Terms of convertible debt and preferred stock instruments are reviewed to determine whether or not they contain embedded derivative instruments that are required under ASC 815 to be accounted for separately from the host contract and recorded on the balance sheet at fair value. The fair value of derivative liabilities, if any, is required to be revalued at each reporting date, with corresponding changes in fair value recorded in current period operating results. Freestanding warrants issued by the Company in connection with the issuance or sale of debt and equity instruments are considered to be derivative instruments. Pursuant to ASC 815, an evaluation of specifically identified conditions is made to determine whether the fair value of warrants issued is required to be classified as equity or as a derivative liability.
Income Taxes	The Company follows the asset and liability approach to accounting for income taxes. Under this method, deferred tax assets and liabilities are measured based on differences between the financial reporting and tax bases of assets and liabilities measured using enacted tax rates and laws that are expected to be in effect when differences are expected to reverse. Valuation allowances are established when it is necessary to reduce deferred income tax assets to the amount, if any, expected to be realized in future years. ASC 740, Accounting for Income taxes (“ASC 740”), requires that deferred tax assets be evaluated for future realization and reduced by a valuation allowance to the extent we believe a portion more likely than not will not be realized. We consider many factors when assessing the likelihood of future realization of our deferred tax assets, including our recent cumulative loss experience and expectations of future taxable income by taxing jurisdictions, the carry forwarding periods available to us for tax reporting purposes and other relevant factors. The Company has not recognized a liability for uncertain tax positions. A reconciliation of the beginning and ending amount of unrecognized tax benefits or penalties has not been provided since there has been no unrecognized benefit or penalty. If there were an unrecognized tax benefit or penalty, the Company would recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. The Company files U.S. Federal income tax returns and various returns in state jurisdictions. The Company's open tax years subject to examination by the Internal Revenue Service and the state Departments of Revenue generally remain open for three years from the date of filing.
Use of Estimates	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and to the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.
Net Loss Per Share	Basic net loss per share is computed by dividing net loss by the weighted average number of shares of Common Stock outstanding for the period. Diluted net loss per share reflects the potential dilution of securities by adding other Common Stock equivalents, including stock options, shares issuable on exercise of warrants, convertible preferred stock and convertible notes in the weighted average number of common shares outstanding for a period, if dilutive. Common stock equivalents that are anti-dilutive were excluded from the computation of diluted earnings per share which consisted of all outstanding common stock options and warrants.
Stock-Based Compensation	The Company uses the fair value method to account for the granting of options to purchase shares of its stock whereby all awards are recorded at fair value on the date of the grant. Share based awards with a performance condition are measured based on the probable outcome of that performance condition during the requisite service period. Such an award with a performance condition is accrued if it is probable that a performance condition will be achieved. Compensation costs for stock-based payments that do not include performance conditions are recognized on a straight-line basis. The fair value of all share purchase options is expensed over their requisite service period with a corresponding increase to additional capital surplus. Upon exercise of share purchase options, the consideration paid by the option holder, together with the amount previously recognized in additional capital surplus, is recorded as an increase to share capital. The Company estimates the fair value of each option award on the date of grant using a Black-Scholes option pricing model that uses the assumptions noted in the table below. The Company estimates the fair value of its common stock using the closing stock price of its common stock on the option grant date. The Company estimates the volatility of its common stock at the date of grant based on its historical stock prices. The Company uses the risk-free interest rate on the implied yield currently available on U.S. Treasury issues with an equivalent remaining term approximately equal to the expected life of the award. The Company has never paid any cash dividends on its common stock and does not anticipate paying any cash dividends in the foreseeable future. The fair value of shares of restricted stock issued are determined by the Company based on the estimated fair value of the Company’s common stock.
Recently Issued Accounting Pronouncements	In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), The Company does not believe that any other issued, but not yet effective accounting standards, if currently adopted, will have a material effect on the Company’s consolidated financial position, results of operations and cash flows.
Going Concern	The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business. For the fiscal year period ended Dec 31, 2020, the Company generated an operating loss of $3,491,241. In addition, the Company has an accumulated deficit, total stockholders’ deficit and net working capital deficit of $77,831,081, $628,940 and $3,031,001 at Dec 31, 2020, respectively. The Company’s activities were primarily financed through private placements of equity securities. The Company intends to raise additional capital through the issuance of debt and/or equity securities to fund its operations. The Company is reliant on future fundraising to finance operations in the near future. The financing may not be available on terms satisfactory to the Company, if at all. In light of these matters, there is substantial doubt that the Company will be able to continue as a going concern. Currently, management intends to develop a vastly improved healthcare communications system and intends to develop alliances with strategic partners to generate revenues that will sustain the Company. While management believes in the viability of its strategy to increase revenues and in its ability to raise additional funds, there can be no assurances to that effect. Management’s ability to continue as a going concern is ultimately dependent upon its ability to continually increase the Company’s customer base and realize increased revenues from signed contracts. The financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

COMMON STOCK (Tables)

COMMON STOCK (Tables)	12 Months Ended
	Dec. 31, 2020
COMMON STOCK (Tables)
Summary of stock option activity	2019 Options Outstanding Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term in Years Aggregate Intrinsic Value Balance Outstanding - January 1, 2018 198,402 $ 10.40 0.7 $ - Granted 1,300,000 $ 0.25 10.2 Exercised - Forfeited/expired (142,245 ) $ 9.05 Balance Outstanding - December 31, 2018 1,356,157 $ 0.31 9.8 $ - Exercisable - December 31, 2018 489,490 $ 0.29 9.1 $ - Balance Outstanding - January 1, 2019 1,356,157 $ 0.31 9.8 $ - Granted 135,000 $ 0.15 9.2 Exercised - Forfeited (81,157 ) $ 1.17 Balance Outstanding - December 31, 2019 1,410,000 $ 0.24 9.2 $ - Exercisable - December 31, 2019 976,667 $ 0.24 9.2 $ - 2019 Nonvested Options Number of Options Weighted Average Grant Date Fair Value Weighted Average Remaining Years to Vest Nonvested - January 1, 2018 18,719 $ 10.40 0.7 Granted 1,300,000 $ 0.13 Vested (452,052 ) $ 0.31 Forfeited/expired - Nonvested - December 31, 2018 866,667 $ 0.13 1.6 Nonvested - January 1, 2019 866,667 $ 0.13 1.6 Granted 135,000 $ 0.15 Vested (568,334 ) $ 0.13 Forfeited/expired - Nonvested - December 31, 2019 433,333 $ 0.13 0.6
Summary of stockholders equity note warrants or rights	2020 Options Outstanding Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term in Years Aggregate Intrinsic Value Balance Outstanding - January 1, 2020 1,410,000 $ 0.24 8.7 $ - Granted - $ - Exercised (5,000 ) $ 0.15 Forfeited - $ - Balance Outstanding - December 31, 2020 1,405,000 $ 0.24 7.7 $ - Exercisable - December 31, 2020 1,405,000 $ 0.24 7.7 $ - 2020 Nonvested Options Number of Options Weighted Average Grant Date Fair Value Weighted Average Remaining Years to Vest Nonvested - January 1, 2020 433,333 $ 0.13 0.6 Granted - $ - Vested (433,333 ) $ 0.13 Forfeited/expired - Nonvested - December 31, 2020 - $ - 0.00

PROPERTY AND EQUIPMENT (Tables)

PROPERTY AND EQUIPMENT (Tables)	12 Months Ended
	Dec. 31, 2020
PROPERTY AND EQUIPMENT
Schedule of Property and equipment	December 31, December 31, 2020 2019 Furniture and fixtures $ 7,740 $ 8,000 Leasehold improvements 26,145 26,000 Equipment 16,439 16,000 $ 50,324 $ 50,000 Less accumulated depreciation (47,919 ) (44,000 ) $ 2,405 $ 6,000

SOFTWARE DEVELOPMENT COSTS (Tab

SOFTWARE DEVELOPMENT COSTS (Tables)	12 Months Ended
	Dec. 31, 2020
SOFTWARE DEVELOPMENT COSTS (Tables)
Summary of capitalization and amortization of software development costs	December 31, December 31, 2020 2019 Development costs $ 2,479,137 $ 1,936,000 Acquired technology 1,527,186 1,277,000 Less accumulated amortization (2,483,622 ) (1,697,000 ) $ 1,522,701 $ 1,516,000

LONG TERM DEBT (Tables)

LONG TERM DEBT (Tables)	12 Months Ended
	Dec. 31, 2020
LONG TERM DEBT
Schedule of maturities of long term debt	December 31 December 31 2019 2020 (1) Note payable bearing interest at 12.0% per annum, due December 31, 2020 $ 118,000 $ 118,000 (2) Related Party Long term debt bearing interest at 8%, due April 15, 2021 100,257 92,602 (3) Related Party Promissory note bearing interest at 18%, due December 31, 2020 535,021 556,331 (4) Convertible note bearing interest at 10%, due July 15, 2021 156,438 81,018 (5) Convertible note bearing interest at 10%, due March 2, 2021 189,444 - (6) Convertible note bearing interest at 10%, due December 16, 2020 - 45,184 1,099,160 893,135 Less current maturities (1,099,160 ) (880,579 ) Total Long-term debt $ - $ 12,556
Summary of future minimum payment long term debt	Total future minimum payments due on long-term debt as of December 31, 2020: 2021 1,099,160 2022 - 1,099,160

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2020
INCOME TAXES
Schedule of deferred tax assets and liabilities	2020 2019 Deferred Income Tax Assets 13,692,000 13,327,000 Valuation Allowance (13,692,000 ) (13,327,000 ) Net Deferred Tax Asset - - Reconciliation of the effective income tax rate to the federal statutory rate: Federal Income Tax Rate 21 % 21 % Change in valuation allowance including the effect of the rate change -21 % -21 % Effective income tax rate 0 % 0 %

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	12 Months Ended
	Dec. 31, 2020
COMMITMENTS AND CONTINGENCIES
Summary of lease commitments	iCoreConnect Lease Commitments as of 12/31/2020 Less than 1 year 1-3 years 3-5 years Total $ 100,114 $ 68,000 $ - $ 168,114
Schedule of components of lease investments	Undiscounted minimum lease commitments $ 168,114 Present value adjustment using incremental borrowing rate (17,637 ) Lease liabilities $ 150,477

BUSINESS COMBINATIONS (Tables)

BUSINESS COMBINATIONS (Tables)	12 Months Ended
	Dec. 31, 2020
BUSINESS COMBINATIONS (Tables)
Schedule of fair value assets and liabilites	Consideration Paid: Cash $ 400,000 Common stock 183,000 $ 583,000 Fair values of identifiable assets acquired and liabilities assumed: Assets acquired: Cash $ 25,000 Other current asset 6,000 Right of Use - Lease 14,000 Fixed Assets 3,000 Customer relationships 450,000 Total assets acquired 498,000 Liabilities assumed: Due to Seller 10,000 Accrued Liability 15,000 Deferred revenue 6,000 Lease Liability 14,000 Total liabilities assumed 45,000 Net assets acquired $ 453,000 Goodwill $ 130,000

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Allowance for doubtful accounts	$ 77,000	$ 17,000
Advertising Costs	70,000	34,000
Accumulated deficit	(77,831,081)	(74,340,000)
Total stockholders' Deficit	(628,940)	465,040	$ (958,136)
Working capital deficit	(3,031,001)
FDIC insured limit	250,000
Operating loss	3,491,241
Goodwill	$ 491,376	$ 393,000
Revenue , description	Approximately 80% of our revenue is subscription based with the remainder being professional services and other IT related revenue. The geographic concentration of our revenue is 100% in North America.
Furniture and Fixtures [Member]
Estimated useful life	7 years
Computers and office equipment [Member]
Estimated useful life	3 years
ICD Logic [Member]
Goodwill	$ 361,000
TrinIT [Member]
Goodwill	$ 130,000

COMMON STOCK (Details)

COMMON STOCK (Details) - $ / shares	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Nonvested Options
Number of Options Nonvested, Granted	1,396,026
2019 [Member]
Options Outstanding
Number of Options/Warrants Outstanding, Beginning	1,356,157	198,402
Number of Options Outstanding, Granted	135,000	1,300,000
Number of Options Outstanding, Forfeited/expired	(81,157)	(142,245)
Number of Options/Warrants Outstanding, Ending	1,410,000	1,356,157
Number of Options Outstanding, Exercisable Ending	976,667	489,490
Weighted Average Exercise Price, Beginning	$ 0.31	$ 10.40
Weighted Average Exercise Price, Granted	0.15	0.25
Weighted Average Exercise Price, Forfeited/expired	1.17	9.05
Weighted Average Exercise Price, Ending	0.24	0.31
Weighted Average Exercise Price, Exercisable Ending	$ 0.24	$ 0.29
Weighted Average Remaining Contractual Term in Years, Beginning	9 years 9 months 18 days	8 months 12 days
Weighted Average Remaining Contractual Term in Years, Granted	9 years 2 months 12 days	10 years 2 months 12 days
Weighted Average Remaining Contractual Term in Years, Ending	9 years 2 months 12 days	9 years 9 months 18 days
Weighted Average Remaining Contractual Term in Years, Exercisable Ending	9 years 2 months 12 days	9 years 1 month 6 days
Nonvested Options
Number of Options Nonvested, Beginning	866,667	18,719
Number of Options Nonvested, Granted	135,000	1,300,000
Number of Options Nonvested, Vested	(568,334)	(452,052)
Number of Options Nonvested, Ending	433,333	866,667
Weighted Average grant date Fair Value Nonvested, Beginning	$ 0.13	$ 10.40
Weighted Average grant date Fair Value Granted	0.15	0.13
Weighted Average grant date Fair Value Vested	0.13	0.31
Weighted Average grant date Fair Value Nonvested, Ending	$ 0.13	$ 0.13
Weighted Average Remaining Years to vest Nonvested, Begining	1 year 7 months 6 days	8 months 12 days
Weighted Average Remaining Years to vest Nonvested, Ending	7 months 6 days	1 year 7 months 6 days

COMMON STOCK (Details 1)

COMMON STOCK (Details 1) - $ / shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Nonvested Options
Number of Options Nonvested, Granted		1,396,026
2020 [Member]
Number of Options Outstanding, Beginning Balance	1,410,000
Number of Options Outstanding, Exercised	(5,000)
Number of Options Outstanding, Ending Balance	1,405,000
Number of Options Exercisable	1,405,000
Weighted Average Exercise Price, Beginning	$ 0.24
Weighted Average Exercise Price, Exercised	0.15
Weighted Average Exercise Price, Ending	0.24
Weighted Average Exercise Price, Exercisable	$ 0.24
Weighted Average Remaining Contractual Term in Years, Beginning	8 years 8 months 12 days
Weighted Average Remaining Contractual Term in Years, Ending	7 years 8 months 12 days
Weighted Average Remaining Contractual Term in Years, Exercisable Ending	7 years 8 months 12 days
Nonvested Options
Number of Options Nonvested, Beginning	433,333
Number of Options Nonvested, Granted
Number of Options Nonvested, Vested
Number of Options Nonvested, Ending	(433,333)
Weighted Average Grant Date Fair Value
Weighted Average grant date Fair Value Nonvested, Beginning	$ 0.13
Weighted Average grant date Fair Value Granted	0
Weighted Average grant date Fair Value Vested	0.13
Weighted Average grant date Fair Value Nonvested, Ending	$ 0
Weighted Average Remaining Years to Vest
Weighted Average Remaining Years to vest Nonvested, Begining	7 months 6 days
Weighted Average Remaining Years to vest Nonvested, Ending	0 years

COMMON STOCK (Details Narrative

COMMON STOCK (Details Narrative) - USD ($)	Apr. 13, 2020	Jan. 03, 2020	Feb. 21, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Common stock shares issued for stock grant				5,000
Common stock shares issued for stock grant, value				$ 1,000	$ 250,000
Common stock shares issued during the period				7,128,002
Proceeds from issuance of common stock				$ 1,050,488	$ 3,197,000
Restricted stock grant during period					1,396,026
Common stock shares issued for services				250,000
Common stock shares issued for services, value				$ 0	$ 17,000
Common stock per share price					$ 0.25
Common stock shares issued for conversion of notes payable, shares				6,761,558	12,435,759
Common stock shares issued for conversion of notes payable, value				$ 201,600	$ 3,217,000
Warrant One [Member]
Warrans expired						$ 72,669
ClariCare Asset Purchase Agreement [Member]
Business acquisition, consideration transferred, shares issued				4,555,994	2,301,007
Warrants [Member]
Share price per share					$ 1.35
Expire date					Dec. 31, 2020
TrinIT [Member]
Business acquisition, consideration transferred, shares issued		730,000		730,000
Director [Member]
Restricted stock grant during period			200,000
Common stock per share price					$ 0.25
Compensation expense					$ 50,000
Board of Directors Chairman [Member]
Compensation expense	$ 50,000
Shares issued/vested	250,000
Share price per share	$ 0.25
Management [Member]
Restricted stock grant during period			475,000
Common stock per share price					$ 0.25
Compensation expense			$ 81,000
Unvested restricted stock excluded from common stock outstanding					262,500
Restricted stock issued/vested, description					212,500 shares vested on the date of the Board of Director approval, with 131,250 shares vesting on each of the next two anniversary dates of the Board of Director approval.
Executives And Directors [Member] | Restricted Stock [Member]
Shares issued/vested					412,500
Stock reserved for future issuance as compensation					675,000
Former employee [Member]
Common stock issued as compensastion, value				$ 423,300
Common stock issued as compensastion				2,124,693	66,666
2020 [Member]
Restricted stock grant during period
Compensation expense				$ 31,000
Restricted stock vested/issued
2020 [Member] | Management [Member]
Compensation expense				$ 33,000
2020 [Member] | Board of Director [Member]
Compensation expense				$ 67,000
April 1, 2018 [Member] | Director [Member]
Common stock shares issued for stock grant				1,000,000
Compensation expense					$ 83,000
Unvested restricted stock excluded from common stock outstanding				333,334
Shares issued/vested				333,333
Share price per share					$ 0.25
2021 [Member] | Management [Member]
Compensation expense				$ 5,000
May 22, 2018 [Member] | Board of Directors Chairman [Member]
Common stock shares issued for stock grant				4,287,161
Compensation expense				$ 179,000
Unvested restricted stock excluded from common stock outstanding					714,527
Shares issued/vested				2,858,107
Share price per share					$ 0.25
Evenly in 2019 and 2020 [Member] | Board of Directors Chairman [Member]
Restricted stock vested/issued				1,429,054
Evenly in 2020 and 2021 [Member] | Executives And Directors [Member] | Restricted Stock [Member]
Shares issued/vested				262,500
Evenly in 2019 and 2020 [Member] | Director [Member]
Shares issued/vested				666,667
Convertible Promissory Note Payable [Member]
Common stock shares issued for conversion of notes payable, shares				1,000,000
Common stock shares issued for conversion of notes payable, value				$ 250,781

PROPERTY AND EQUIPMENT (Details

PROPERTY AND EQUIPMENT (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Property, plant and equipment, gross	$ 50,324	$ 50,000
Less accumulated depreciation	(47,919)	(44,000)
Property, plant and equipment, net	2,405	6,000
Equipment [Member]
Property, plant and equipment, gross	16,439	16,000
Furniture and Fixtures [Member]
Property, plant and equipment, gross	7,740	8,000
Leasehold improvements [Member]
Property, plant and equipment, gross	$ 26,145	$ 26,000

PROPERTY AND EQUIPMENT (Detai_2

PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
PROPERTY AND EQUIPMENT
Depreciation expense	$ 6,595	$ 5,000

SOFTWARE DEVELOPMENT COSTS (Det

SOFTWARE DEVELOPMENT COSTS (Details) - Software Development [Member] - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Development costs	$ 2,479,137	$ 1,936,000
Acquired technology	1,527,186	1,277,000
Less Accumulated amortization	(2,482,622)	(1,697,000)
Total Software development costs	$ 1,522,701	$ 1,516,000

SOFTWARE DEVELOPMENT COSTS (D_2

SOFTWARE DEVELOPMENT COSTS (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
SOFTWARE DEVELOPMENT COSTS
Amortization of software development	$ 899,000	$ 628,000

LONG TERM DEBT (Details)

LONG TERM DEBT (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Less current maturities	$ (880,579)	$ (1,099,160)
Total Long-term debt	12,556	0
Notes Payables [Member]
Total Long-term debt	118,000	118,000
Notes Payable One [Member]
Total Long-term debt	92,602	100,257
Notes Payable Two [Member]
Total Long-term debt	556,331	535,021
Notes Payable Three [Member]
Total Long-term debt	81,018	156,438
Notes Payable Four [Member]
Total Long-term debt	0	189,444
Notes Payable Five [Member]
Total Long-term debt	45,184	0
Notes Payable Six [Member]
Total Long-term debt	$ 893,135	$ 1,099,160

LONG TERM DEBT (Details 1)

LONG TERM DEBT (Details 1)	Dec. 31, 2020USD ($)
LONG TERM DEBT
2021	$ 1,099,160
2022	0
Long-term debt, maturities	$ 1,099,160

LONG TERM DEBT (Details Narrati

LONG TERM DEBT (Details Narrative) - USD ($)	1 Months Ended		12 Months Ended
	Aug. 31, 2019	Dec. 31, 2018	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Note payable				$ 100,000
Convertible promissory note payable				$ 45,000
Conversion percentage				4.99%
Description			One hundred eighty (180) days following the date of funding and thereafter, the note was convertible into common stock of the Company ("Common Stock"). The conversion price of the Note was 61% of the Market Price (as defined in the Note) for the Common Stock (a discount of 39%).
Accrued interest				$ 18,000
Closing fees				$ 40,000
Interest rate				10.00%
January 2021 [Member]
Conversion of shares into common stock			2,720,000
Promissory Note [Member]
Note payable		$ 100,000		$ 100,000	$ 100,000
Interest rate		18.00%		12.00%	12.00%
Debt maturity date				Dec. 31, 2020	Dec. 31, 2019
Convertible Promissory Note Payable [Member]
Convertible promissory note payable	$ 78,000			$ 78,000
Conversion percentage			4.99%
Description			One hundred eighty (180) days following the date of funding and thereafter, the note was convertible into common stock of the Company ("Common Stock"). The conversion price of the Note was 61% of the Market Price (as defined in the Note) for the Common Stock (a discount of 39%).
Accrued interest				3,000
Closing fees	$ 75,000
Interest rate	10.00%
Notes Payables [Member]
Note payable		$ 714,000	$ 556,000	$ 556,000	$ 714,000
Description			Subsequent to the end of fiscal 2020, the maturity on note payable to the related party was extended to a new 2-year term note payable bearing interest rate payable of 18% per annum with a maturity date of December 31, 2023. The note will pay monthly cash interest only in the first year (12 months) of note payable term. In the 2nd year, the note payable will be repaid with 12 monthly installment payments of interest and principal until fully repaid.
Accrued interest			$ 535,021
Interest rate				18.00%	18.00%
Debt maturity date				Dec. 31, 2020	Dec. 31, 2019

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
INCOME TAXES
Deferred Income Tax Assets	$ 13,692,000	$ 13,327,000
Valuation Allowance	(13,692,000)	(13,327,000)
Net Deferred Tax Asset	$ 0	$ 0

INCOME TAXES (Details 1)

INCOME TAXES (Details 1)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
INCOME TAXES
Federal Income Tax Rate	21.00%	21.00%
Change in valuation allowance including the effect of the rate change	(21.00%)	(21.00%)
Effective income tax rate	0.00%	0.00%

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
INCOME TAXES
Operating loss carryforwards, federal		$ (9,924,000)
Description of operating loss carryforwards, federal	Federal net operating loss carryforwards of approximately $55,276,000 which at the latter date may be carried forward for tax years ending through December 31, 2037.

CONCENTRATION OF CREDIT RISK (D

CONCENTRATION OF CREDIT RISK (Details Narrative)	12 Months Ended
	Dec. 31, 2020
CONCENTRATION OF CREDIT RISK (Details Narrative)
Revenue percentage	13.00%
Total revenue percentage	21.00%
Description	The company has accounts receivable concentration with two customers that represent 21% and 16% of our accounts receivable.Overall, the company grew its accounts receivable approximately ending balance 25% in 2020 from year-end 2019, compared to an over 100% growth in sales for 2020. Day’s sales outstanding was less than 30 days at fiscal year-end 2020.

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES (Details)	Dec. 31, 2020USD ($)
Lease Commitments	$ 168,114
3-5 years [Member]
Lease Commitments	0
Less than 1 year [Member]
Lease Commitments	100,114
1-3 years [Member]
Lease Commitments	$ 68,000

COMMITMENTS AND CONTINGENCIES_3

COMMITMENTS AND CONTINGENCIES (Details 1) - Lease [Member]	Dec. 31, 2020USD ($)
Undiscounted minimum lease commitments	$ 168,114
Present value adjustment using incremental borrowing rate	(17,637)
Lease liabilities	$ 150,477

COMMITMENTS AND CONTINGENCIES_4

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Lease [Member]
Payments of lease liabilities		$ 57,000
Lease costs	$ 123,500
Undiscounted minimum lease commitments	$ 68,000
November 15, 2017 [Member] | Lease Agreement [Member]
Term of lease agreement	An amendment to this lease was signed on October 26, 2020 which extended the lease term through October 31, 2021.
Lease term	3 years
January 1, 2019 [Member] | Lease [Member]
Weighted-average incremental borrowing rate	11.90%
Weighted-average remaining lease term	1 year 7 months 6 days
Murali Chakravarthi [Member] | November 1, 2019 [Member] | Chakravarthi 2018 Agreement [Member]
Common stock shares issuable upon exercise of stock options vested	100,000
Murali Chakravarthi [Member] | November 1, 2020 [Member] | Chakravarthi 2018 Agreement [Member]
Common stock shares issuable upon exercise of stock options vested	100,000
Murali Chakravarthi [Member] | November 1, 2018 [Member] | Chakravarthi 2018 Agreement [Member]
Common stock shares issuable upon exercise of stock options vested	100,000
Annual base salary	$ 120,000
Term of agreement	3 years
Common stock shares issuable upon exercise of stock options	300,000
Description for the termination of agreement	(i) due to a change in control Mr. Chakravarthi will continue to receive his base salary and his annual bonus computed at 100% of his base salary for the six month period following the date of termination, (ii) due to death or disability Mr. Chakravarthi or his estate will continue to receive his base salary during the six month period following the date of termination and (iii) by the Company without cause Mr. Chakravarthi will continue to receive his base salary for the six month period following the date of termination or through the end of the employment period, whichever is longer.
David Fidanza [Member] | October 1, 2020 [Member] | Fidanza 2018 Agreement [Member]
Common stock shares issuable upon exercise of stock options vested	100,000
Annual base salary	$ 130,000
David Fidanza [Member] | October 1, 2019 [Member] | Fidanza 2018 Agreement [Member]
Common stock shares issuable upon exercise of stock options vested	100,000
Annual base salary	$ 125,000
David Fidanza [Member] | October 1, 2018 [Member] | Fidanza 2018 Agreement [Member]
Common stock shares issuable upon exercise of stock options vested	100,000
Annual base salary	$ 115,000
Term of agreement	3 years
Common stock shares issuable upon exercise of stock options	300,000
Description for the termination of agreement	(i) due to a change in control Mr. Fidanza will continue to receive his base salary and his annual bonus computed at 100% of his base salary for the six month period following the date of termination, (ii) due to death or disability Mr. Fidanza or his estate will continue to receive his base salary during the six month period following the date of termination, (iii) by the Company without cause Mr. Fidanza will continue to receive his base salary for the six month period following the date of termination or through the end of the employment period, whichever is longer
Robert McDermott [Member] | Employment agreement [Member]
Restricted shares issued/awarded as bonus	800,000		350,000
Bonus paid to officer under agreement	$ 75,000
Robert McDermott [Member] | July 1, 2019 [Member] | Employment agreement [Member]
Common stock shares issuable upon exercise of stock options vested	233,333
Annual base salary	$ 262,500
Robert McDermott [Member] | July 1, 2020 [Member] | Employment agreement [Member]
Common stock shares issuable upon exercise of stock options vested	233,334
Annual base salary	$ 275,500
Robert McDermott [Member] | July 1, 2018 [Member] | Employment agreement [Member]
Common stock shares issuable upon exercise of stock options vested	233,333
Annual base salary	$ 250,000
Term of agreement	3 years 6 months
Common stock shares issuable upon exercise of stock options	700,000
Description for the termination of agreement	(i) due to a change in control Mr. McDermott will continue to receive his base salary and his annual bonus computed at 100% of his base salary for the 24 month period following the date of termination, (ii) due to death or disability Mr. McDermott or his estate will continue to receive his base salary during the six month period following the date of termination, (iii) by the Company without cause Mr. McDermott will continue to receive his base salary for the 18 month period following the date of termination or through the end of the employment period, whichever is longer
Robert McDermott [Member] | July 1, 2021 [Member] | Employment agreement [Member]
Annual base salary	$ 289,000

BUSINESS COMBINATIONS (Details)

BUSINESS COMBINATIONS (Details) - TrinIT [Member]	Dec. 31, 2020USD ($)
Cash	$ 400,000
Common stock	183,000
Net asset acquired	$ 583,000

BUSINESS COMBINATIONS (Details

BUSINESS COMBINATIONS (Details 1) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Liabilities assumed:
Goodwill	$ 491,376	$ 393,000
TrinIT [Member]
Assets acquired
Cash	25,000
Other current asset	6,000
Right of Use - Lease	14,000
Fixed Assets	3,000
Customer relationships	450,000
Total assets acquired	498,000
Liabilities assumed:
Due to Seller	10,000
Accrued Liability	15,000
Deferred revenue	6,000
Lease Liability	14,000
Total liabilities assumed	45,000
Net asset acquired	453,000
Goodwill	$ 130,000

BUSINESS COMBINATIONS (Detail_2

BUSINESS COMBINATIONS (Details Narrative) - USD ($)	1 Months Ended			12 Months Ended
	Sep. 30, 2020	Jan. 03, 2020	Apr. 30, 2019	Dec. 31, 2020	Dec. 31, 2019
Common stock shares issued				90,081,336	67,476,089
ClariCare Asset Purchase Agreement [Member]
Business acquisition, consideration transferred, shares issued				4,555,994	2,301,007
Common stock shares issued	4,555,974
Increase in asset	$ 250,580
ClariCare Inc. [Member]
Business acquisition, consideration transferred, shares issued			2,301,007
Business acquisition consideration transferred in cash			$ 50,000
Business acquisition, description for assumption of certain liabilities payable			the assumption of certain specified liabilities including a company credit card balance not to exceed $23,000, all upon the terms and conditions set forth in the Asset Purchase Agreement dated as of April 30, 2019
TrinIT [Member]
Business acquisition, consideration transferred, shares issued		730,000		730,000
Cash		$ 400,000
Annual customer attrition rate		8.00%
Gross margin percentage		55.00%
Tax rate		23.50%
Discount rate		12.00%

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	Jan. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Mar. 31, 2021
Note payable			$ 100,000
Common stock shares issued for services, value		$ 0	$ 17,000
Common stock shares issued for cash, shares		6,761,558	12,435,759
Common stock shares issued for cash, value		$ 201,600	$ 3,217,000
First Finance Company [Member]
Note payable		$ 61,764
Subsequent Event [Member] | Executive And Employee [Member]
Common stock shares issued for services, shares	16,400,000
Common stock shares issued for services, value	$ 819,000
Common stock shares issued for cash, shares	23,000,000
Common stock shares issued for cash, value	$ 1,100,000
Subsequent Event [Member] | Purchase Agreement [Member]
Restricted shares of common stock	250,000
Agreement descriptions	The Purchase Agreement provides that at any time after the effective date of the Registration Statement, from time to time on any business day selected by the Company, the Company shall have the right, but not the obligation, to direct the Investor to buy the lesser of $250,000 or 300% of the average shares traded for the 10 days prior to the closing request date, at a purchase price of 75% of the lowest daily traded VWAP price during the five trading days preceding the draw down or put notice, with a minimum purchase price request of $25,000.
Subsequent Event [Member] | Purchase Agreement [Member] | Investor [Member]
Line of credit descriptions	The Purchase Agreement is an equity line of credit and the Investor committed to purchase, subject to certain restrictions and conditions, up to $5.0 million worth (the “Commitment”) of the Company’s common stock over a period of 24 months
Subsequent Event [Member] | Third Finance Company [Member]
Note payable	$ 135,520
Subsequent Event [Member] | Finance Company [Member]
Note payable				$ 135,520
Subsequent Event [Member] | Second Finance Company [Member]
Note payable	$ 150,309